A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients

NCT03099876 · clinicaltrials.gov ↗

UNKNOWN

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

PROCEDURE: treatment period

Sponsor

Il-Yang Pharm. Co., Ltd.